Healthcare

AstraZeneca asks FDA to sign off on self-administered flu vaccine

By Gabrielle M. Etzel
Published October 24, 2023 7:22pm ET
Add Washington Examiner on Google
AstraZeneca asks FDA to sign off on self-administered flu vaccine
British pharmaceutical company AstraZeneca applied on Tuesday for permission from the U.S. Food and Drug Administration to market a self-administered, needle-free nasal spray vaccine for annual flu protection. Executive Vice President for Vaccines and Immune Therapies Iskra Reic said in a press statement that the product FluMist has been a “critical public health tool” for […]

British pharmaceutical company AstraZeneca applied on Tuesday for permission from the U.S. Food and Drug Administration to market a self-administered, needle-free nasal spray vaccine for annual flu protection.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

FDA Infectious Disease Pharmaceutical Industry